Medical oncology: Multimodality therapy in unresectable colorectal cancer.
Mathis et al. aimed to determine the effect of multimodality therapy on recurrence and survival in patients with locally advanced colorectal cancer. Use of multimodality treatment led to excellent local control with five year disease-free and overall survival rates comparable to that of stage-matched resectable colorectal cancers.
Popowich
Daniel A
DA
Division of Gastrointestinal and Oncologic Surgery, Feinberg School of Medicine, Northwestern University, 676 North St Claire, Chicago, IL 60611, USA.
Halverson
Amy L
AL
D000230:Adenocarcinoma / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D003131:Combined Modality Therapy; D013505:Digestive System Surgical Procedures; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis; D011878:Radiotherapy; D015996:Survival Rate; D016896:Treatment Outcome
D000970:Antineoplastic Agents